NIVFNasdaqServices-Misc Health & Allied Services, NECAlso trades as NIVFW
NewGenIvf Group Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026
$0.28+0.00 (+1.47%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 0.1
- Dividend yield
- –
NewGenIvf Group Ltd revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| IVF treatment service [Member] | $3.91M | $5.43M | $4.02M | $2.82M | $3.20M | 82.6% | -28.1% |
| Fertility referral services [Member] | $820.57K | – | – | – | – | 17.4% | – |
| Surrogacy, ancillary caring and other services [Member] | – | – | $1.11M | $3.13M | $918.44K | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| Kyrgyzstan | $2.31M | $2.66M | $3.12M | $5.06M | $3.11M | 48.9% | -13.0% |
| Thailand | $1.69M | $2.18M | $1.36M | $505.61K | $693.90K | 35.8% | -22.2% |
| Cambodia | $635.19K | $601.53K | $621.62K | $377.61K | $313.74K | 13.4% | +5.6% |
| Hong Kong SAR China | $209.63K | $3.08K | $34.04K | – | – | 4.4% | +6704.0% |
| United States | $45.48K | – | – | – | – | 1.0% | – |
| China / HK SAR [Member] | $41.56K | – | – | – | – | 0.9% | – |
| HK SAR [Member] | – | – | $34.04K | – | – | – | – |
| China | – | $8.37K | – | – | – | – | – |
From the segment and revenue-disaggregation notes of NewGenIvf's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.